The epidemiology of enterococci
- PMID: 2180711
- DOI: 10.1007/BF01963631
The epidemiology of enterococci
Abstract
The enterococci are emerging as a significant cause of nosocomial infections, accounting for approximately 10% of hospital acquired infections. They are found as normal inhabitants of the human gastrointestinal tract, but may also colonize the oropharynx, vagina, perineal region and soft tissue wounds of asymptomatic patients. Until recently, evidence indicated that most enterococcal infections arose from patients' own endogenous flora. Recent studies, however, suggest that exogenous acquisition may occur and that person-to-person spread, probably on the hands of medical personnel, may be a significant mode of transmission of resistant enterococci within the hospital. The use of broad-spectrum antibiotics, especially cephalosporins, is another major factor in the increasing incidence of enterococcal infections. These findings suggest that barrier precautions, as applied with other resistant nosocomial pathogens, along with more judicial use of antibiotics may be beneficial in preventing nosocomial spread of resistant enterococci.
Similar articles
-
Clinical manifestations of enterococcal infection.Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):111-7. doi: 10.1007/BF01963635. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2180706 Review.
-
The epidemiology of nosocomial enterococcal urinary tract infection.Am J Med Sci. 1976 Jul-Aug;272(1):75-81. doi: 10.1097/00000441-197607000-00009. Am J Med Sci. 1976. PMID: 822713
-
Nosocomial enterococcal infections: association with use of third-generation cephalosporin antibiotics.Am J Infect Control. 1988 Dec;16(6):241-5. doi: 10.1016/s0196-6553(88)80002-6. Am J Infect Control. 1988. PMID: 3264666
-
Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital.Surg Gynecol Obstet. 1987 Oct;165(4):339-42. Surg Gynecol Obstet. 1987. PMID: 3660197
-
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.Medicine (Baltimore). 1988 Jul;67(4):248-69. Medicine (Baltimore). 1988. PMID: 3134590 Review.
Cited by
-
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z. BMC Microbiol. 2025. PMID: 39979834 Free PMC article.
-
A Type I Restriction-Modification System Associated with Enterococcus faecium Subspecies Separation.Appl Environ Microbiol. 2019 Jan 9;85(2):e02174-18. doi: 10.1128/AEM.02174-18. Print 2019 Jan 15. Appl Environ Microbiol. 2019. PMID: 30389763 Free PMC article.
-
Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom.J Clin Microbiol. 1992 Aug;30(8):1953-7. doi: 10.1128/jcm.30.8.1953-1957.1992. J Clin Microbiol. 1992. PMID: 1500498 Free PMC article.
-
Potential impact of antimicrobial resistance in wildlife, environment and human health.Front Microbiol. 2014 Feb 5;5:23. doi: 10.3389/fmicb.2014.00023. eCollection 2014. Front Microbiol. 2014. PMID: 24550896 Free PMC article. Review.
-
Enterococcus faecium in hospitals.Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):113-9. doi: 10.1007/BF01709469. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9105837 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical